Skip to main content
. 2022 Aug 18;13:990800. doi: 10.3389/fmicb.2022.990800

Table 5.

The top 20 most-cited references published in the last 5  years.

No. Authors Year, journal, title Citations Topics Types
1 Defilipp Z 2019, N Engl J Med, Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant 226 Drug-Resistant bacteremia Case report
2 Costello SP 2019, JAMA, Effect of fecal microbiota transplantation on 8-Week remission in patients with ulcerative colitis: a randomized clinical trial 214 Ulcerative colitis Clinical trial
3 Routy B 2018, Science, Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors 203 Tumor Clinical trial
4 Gopalakrishnan V 2018, Science, Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients 171 Tumor Clinical trial
5 Halkjaer SI 2018, Gut, Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomized, double-blind placebo-controlled study 98 Irritable bowel syndrome Clinical trial
6 Wilson BC 2019, Front Cell Infect Microbiol, The super-donor phenomenon in fecal microbiota transplantation 94 Super-donor Review
7 Suez J 2018, Cell, Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT 87 Antibiotics-associated dysbiosis Clinical trial
8 Wang YH 2019, Nat Med, Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis 87 Inhibitor-associated colitis Case report
9 Bolyen E 2019, Nat Biotechnol, Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 85 QIIME Analysis method
10 allegretti jr 2019, Lancet, The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications 77 Faecal microbiota transplantation Review
11 Paramsothy S 2019, Gastroenterology, Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis 76 Ulcerative colitis Clinical trial
12 Ianiro G 2018b, Aliment Pharmacol Ther, Randomized clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 73 Clostridium difficile infection Clinical trial
13 Ianiro G 2018a, United European Gastroenterol J, Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: a systematic review and meta-analysis 73 Clostridium difficile infection Meta analysis (Review)
14 Smillie CS 2018, Cell Host Microbe, Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation 73 Bacterial Engraftment and efficacy Clinical trial
15 Zuo T 2018,Gut, Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome 73 Bacteriophage transfer and efficacy Clinical trial
16 Defilipp Z 2018, Blood Adv, Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity 70 Allogeneic hematopoietic cell transplantation Clinical trial
17 Kang DW 2019, Sci Rep, Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota 70 Autism Clinical trial
18 Zhang Fm 2018, Protein Cell, Microbiota transplantation: concept, methodology and strategy for its modernization 70 Faecal microbiota transplantation Review
19 El-salhy M 2020, Gut, Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomized, double-blind, placebo-controlled study 69 Irritable bowel syndrome Clinical trial
20 Taur Y 2018, Sci Transl Med, Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant 69 Antibiotics-associated dysbiosis Clinical trial